Software developer Accelrys reportedly snapped up Ireland-based software business Qumas after a series of takeover deals. The latest transaction is valued at $50 million, according to Fierce Biotech IT.

With its new acquisition, Accelrys plans to integrate Qumas' regulatory document management system with its existing offerings. Accelrys offers electronic laboratory notebooks, software packages, and laboratory information management systems that could be potential data sources for the products of Qumas. Accelrys aims to build a platform for discovery and research and development through manufacturing and supply, the report detailed. 

The strategic move was partly driven by a belief that Qumas helps biopharma firms manage regulatory files in an era of joint ventures and outsourcing. Accelrys Chief Executive Officer Max Carnecchia also said Qumas' ability to establish a secure, cloud-based system for different internal and external teams was one of the their motivations for the takeover, the report explained.

In addition, purchasing Qumas gives Accelrys link to shared customers including pharmaceutical firms Boehringer Ingelheim, Takeda, and Johnson & Johnson among many others, Fierce Biotech IT reported.